ARMISTICE CAPITAL, LLC - SUPERNUS PHARMACEUTICALS INC ownership

SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 226 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 0.86 and the average weighting 0.2%.

Quarter-by-quarter ownership
ARMISTICE CAPITAL, LLC ownership history of SUPERNUS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$140,386,440
-7.3%
5,092,000
+1.1%
2.15%
-1.8%
Q2 2023$151,382,160
-3.9%
5,036,000
+15.8%
2.19%
-3.5%
Q1 2023$157,600,500
+1.4%
4,350,000
-0.1%
2.27%
-16.3%
Q4 2022$155,378,520
-0.1%
4,356,000
-5.2%
2.71%
+0.5%
Q3 2022$155,473,000
+14.1%
4,593,004
-2.5%
2.70%
+13.5%
Q2 2022$136,271,000
+36.0%
4,712,000
+52.0%
2.38%
+22.7%
Q1 2022$100,192,000
-16.9%
3,100,000
-25.0%
1.94%
-1.9%
Q4 2021$120,606,000
+16.0%
4,136,000
+6.1%
1.97%
+12.0%
Q3 2021$104,013,000
+1.6%
3,900,000
+17.3%
1.76%
-3.8%
Q2 2021$102,346,000
+14.6%
3,324,000
-2.6%
1.83%
-10.7%
Q1 2021$89,326,000
+13.8%
3,412,000
+9.4%
2.05%
-23.2%
Q4 2020$78,499,000
+17.7%
3,120,000
-2.5%
2.67%
+10.4%
Q3 2020$66,688,000
+27.2%
3,200,000
+44.9%
2.42%
+5.2%
Q2 2020$52,440,000
-2.8%
2,208,000
-26.4%
2.30%
-31.1%
Q1 2020$53,970,000
+32.9%
3,000,000
+75.2%
3.34%
+42.4%
Q4 2019$40,609,0001,712,0002.34%
Other shareholders
SUPERNUS PHARMACEUTICALS INC shareholders Q2 2021
NameSharesValueWeighting ↓
ASHFORD CAPITAL MANAGEMENT INC 698,676$41,816,0005.51%
Provident Investment Management, Inc. 543,194$32,510,0004.61%
NEUMEIER POMA INVESTMENT COUNSEL LLC 426,250$25,511,0002.37%
KOPP INVESTMENT ADVISORS LLC 41,879$2,506,0002.35%
AlphaOne Investment Services, LLC 126,279$7,558,0002.17%
Ranger Investment Management 468,933$28,066,0001.96%
Bruce & Co., Inc. 158,058$9,459,0001.88%
Penserra Capital Management LLC 244,371$29,030,0001.83%
SHAKER INVESTMENTS LLC/OH 49,642$2,971,0001.83%
Bridge City Capital, LLC 47,795$2,861,0001.81%
View complete list of SUPERNUS PHARMACEUTICALS INC shareholders